Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Asacol 800mg MR gastro-resistant tablets
0105010B0BBAFAS
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | 17,368 |
|
Asacol 400mg MR gastro-resistant tablets
0105010B0BBAAAA
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | 13,645 |
|
Asacol 500mg suppositories
0105010B0BBACAB
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | 6 |
|
Asacol 1g/application foam enema
0105010B0BBAEAK
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Asacol 250mg suppositories
0105010B0BBADAG
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.